Strategic Partnership Leverage Ellegaard Göttingen Minipigs as a high health, well-documented non-rodent model provider to support pharma companies seeking reliable translational data and regulatory-compliant animal studies, including their igG humanized minipigs for more clinically relevant research.

Global Supply Target multinational CROs and pharmaceutical firms requiring standardized, SPF facility breeding and health-monitored colonies to ensure consistent study results across global trials, highlighting their AAALAC-accredited facility and six-month health monitoring.

End-to-End Services Position their offering as an integrated solution including breeding, research services with an in-house surgical suite, and training through the Göttingen Minipigs Academy to reduce vendor fragmentation and accelerate study start-up timelines.

Regulatory Readiness Emphasize alignment with global regulatory expectations for non-rodent models, leveraging documented health monitoring reports and stable genetic background to support risk assessments, GLP-like workflows, and dossier readiness.

Digital Outreach Utilize their digital presence and partnerships (Exemplar Genetics collaboration, LinkedIn Ads, and analytics tools) to run targeted campaigns highlighting model quality, welfare standards, and case studies that demonstrate translational relevance to drug development pipelines.